<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26948" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neuroanatomy, Periaqueductal Gray</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mokhtar</surname>
            <given-names>Miriam</given-names>
          </name>
          <aff>MCG</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Paramvir</given-names>
          </name>
          <aff>Augusta University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Miriam Mokhtar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Paramvir Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26948.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The periaqueductal gray (PAG) is a key structure in the propagation and modulation of pain, sympathetic responses as well as the learning and action of defensive and aversive behaviors. Most notably, the PAG is largely responsible for descending modulation of pain perception, both in inhibition and facilitation, as pain does not depend on peripheral stimulation alone.<xref ref-type="bibr" rid="article-26948.r1">[1]</xref><xref ref-type="bibr" rid="article-26948.r2">[2]</xref><xref ref-type="bibr" rid="article-26948.r3">[3]</xref>&#x000a0;Both suppression&#x000a0;and&#x000a0;facilitation of pain via these pathways is a&#x000a0;major component of chronic pain, which can lead to further disease states such as depression and anxiety, thus guiding the focus of clinical studies and therapies.</p>
        <p>The PAG also participates in risk assessment, and responses to threats, aiding in defensive behaviors. These pathways give rise to learned aversive behaviors by the involvement of sympathetic responses, motor responses, emotional reactions, and elevating levels of awareness. Mice and rat models demonstrating aversive memory formation to pain related to the PAG highlights the important implications of this structure in our interactions with the environment. Further, this highlights the integral effects the PAG can have not only on the modulation of pain but the subsequent long-term impact in behavioral and memory responses to painful stimuli.</p>
        <p>The role of the PAG with autonomic excitability not only contributes to defensive behaviors but also disease states that are affected by this activation, including panic attacks and anxiety.<xref ref-type="bibr" rid="article-26948.r4">[4]</xref><xref ref-type="bibr" rid="article-26948.r5">[5]</xref>&#x000a0;Through its complex relationship with pain processing, research has shown that the PAG to become activated in those with depression. More recently identified, the PAG is involved with migraines as a possible initiator of attacks.<xref ref-type="bibr" rid="article-26948.r6">[6]</xref></p>
      </sec>
      <sec id="article-26948.s2" sec-type="Structure and Function">
        <title>Structure and Function</title>
        <p>The periaqueductal gray is aptly named as the gray matter structure surrounding the aqueduct of Sylvius in the midbrain. Along the caudal-rostral axis, the PAG extends from the level of the posterior commissure down to the level of the locus coeruleus. Internally, the PAG is delineated by columnal based boundaries: the dorsal PAG (dPAG), dorsolateral PAG (dlPAG), the lateral PAG (lPAG) and the ventrolateral PAG (vlPAG).<xref ref-type="bibr" rid="article-26948.r7">[7]</xref><xref ref-type="bibr" rid="article-26948.r8">[8]</xref>&#x000a0;These columns are based on chemical pathways by which afferent and efferent tracts appear to travel, corresponding to functional pathways.<xref ref-type="bibr" rid="article-26948.r7">[7]</xref></p>
        <p>Several neurotransmitters are involved in the transmission of signals to and from the PAG. Inhibitory serotonergic projections are considered the key component of descending pain pathways. However, norepinephrine, dopamine, enkephalin, glutamate, mu-opioid receptors, and GABAergic neurons contribute in this sense as well.<xref ref-type="bibr" rid="article-26948.r2">[2]</xref><xref ref-type="bibr" rid="article-26948.r3">[3]</xref><xref ref-type="bibr" rid="article-26948.r2">[2]</xref><xref ref-type="bibr" rid="article-26948.r9">[9]</xref>&#x000a0;Serotonin, enkephalin, mu-opioid, and GABAergic receptors are involved in descending pain control pathways, mediated by interneurons.<xref ref-type="bibr" rid="article-26948.r1">[1]</xref><xref ref-type="bibr" rid="article-26948.r2">[2]</xref><xref ref-type="bibr" rid="article-26948.r10">[10]</xref>&#x000a0;Catecholamines (epinephrine and norepinephrine) are found in high concentrations in the vlPAG, contributing to heightened arousal in response to pain.<xref ref-type="bibr" rid="article-26948.r11">[11]</xref></p>
        <p>
<italic toggle="yes">PAIN CONTROL</italic>
</p>
        <p>The PAG plays a major role in the modulation and perception of pain. Initial recognition of this structure stemmed from the observation that stimulation of the PAG before surgery resulted in decreased anesthetic requirements.<xref ref-type="bibr" rid="article-26948.r12">[12]</xref>&#x000a0;Through both ascending and descending projections, the PAG can lessen or augment pain perception as it propagates nociceptive and analgesic stimuli in a bidirectional manner.<xref ref-type="bibr" rid="article-26948.r2">[2]</xref>&#x000a0;Initial pain signals ascend through the dorsal horn, specifically through lamina I (superficial dorsal horn), lamina II (substantia gelatinosa), and lamina V (deep dorsal horn). Those signals, via the spinothalamic and spinobulbar pathways, further ascend to the PAG and other structures to be relayed to the non-specific medial thalamus.<xref ref-type="bibr" rid="article-26948.r1">[1]</xref><xref ref-type="bibr" rid="article-26948.r2">[2]</xref>&#x000a0;Pain pathways have been extensively researched but remain complex. Specific higher structures identified in bidirectional control of pain include the cingulate gyrus, insular cortices, amygdala, periventricular and posterolateral hypothalamus, PAG, ventromedial medulla (VMM) and dorsolateral pontine tegmentum.<xref ref-type="bibr" rid="article-26948.r1">[1]</xref><xref ref-type="bibr" rid="article-26948.r13">[13]</xref><xref ref-type="bibr" rid="article-26948.r14">[14]</xref></p>
        <p>The PAG has two major descending pathways involving the rostral ventromedial medulla (RVMM) and the locus coeruleus (LC). The PAG -LC pathway propagates by norepinephrine (NE), exerting an antinociceptive effect in the dorsal horn via the presynaptic alpha-2 receptor.<xref ref-type="bibr" rid="article-26948.r14">[14]</xref><xref ref-type="bibr" rid="article-26948.r15">[15]</xref>&#x000a0;The serotonergic PAG- RVMM pathway is considered the key endogenous modulator of pain, constituting a primary target for supraspinal opioid analgesia.<xref ref-type="bibr" rid="article-26948.r3">[3]</xref><xref ref-type="bibr" rid="article-26948.r15">[15]</xref>&#x000a0;Specifically, the PAG activates the raphe nuclei via glutamate, and the raphe nuclei activate enkephalin neurons, causing inhibitory signals to c-fiber pain afferents <xref ref-type="bibr" rid="article-26948.r8">[8]</xref>. Specific serotonin receptors have been implicated for their antinociceptive effects in the PAG, including 5-HT.<xref ref-type="bibr" rid="article-26948.r1">[1]</xref></p>
        <p>Though the serotonergic pathway is the major influencer of pain, other key neurotransmitters have demonstrated involvement in these pathways. Glutamate, when applied to the central amygdala and PAG of rats in experimental settings, demonstrated analgesic properties via higher thresholds for paw withdrawal to pain. However, complexity in this system requires emphasis as activation of the &#x0201c;ON-cells&#x0201d; in the PAG has also shown pro-nociceptive effects.<xref ref-type="bibr" rid="article-26948.r10">[10]</xref>&#x000a0;Largely the vlPAG connected with the PFC, amygdala, and ventromedial nucleus (VMN) have been identified in the pain pathway.<xref ref-type="bibr" rid="article-26948.r8">[8]</xref></p>
        <p>
<italic toggle="yes">DEFENSIVE BEHAVIOR</italic>
</p>
        <p>The PAG is a key component in defensive and aversive behavior, mediated by emotional and autonomic arousal. The PAG is the source of unpleasant sensations, including fear, anxiety, and danger.<xref ref-type="bibr" rid="article-26948.r15">[15]</xref>&#x000a0;Chemical stimulation of the dlPAG via NMDA in rodents demonstrates the manifestations of these sensations, such as freezing, running, and avoidance.<xref ref-type="bibr" rid="article-26948.r16">[16]</xref><xref ref-type="bibr" rid="article-26948.r17">[17]</xref>&#x000a0;In addition to emotional arousal, autonomic and cardiopulmonary excitation are also elicited in this structure via sympathetic premotor neurons in the rostral ventrolateral medulla (RVLM). Projections from the vlPAG and dPAG to the RVLM, a component of the reticular formation and arousal pathway, are shown to illicit cardiopulmonary excitation with elevated blood pressure, heart rate, and alertness during stress responses.<xref ref-type="bibr" rid="article-26948.r11">[11]</xref>&#x000a0;Interestingly, specific neural subsets have appeared to relate to risk assessment before subsequent defensive behaviors.<xref ref-type="bibr" rid="article-26948.r17">[17]</xref>&#x000a0;This anticipation is a behavioral strategy aimed at decreasing future pain stimuli.<xref ref-type="bibr" rid="article-26948.r3">[3]</xref>&#x000a0;The combination of these sensations contributes to learned aversive and defensive behaviors in response to stressful stimuli.<xref ref-type="bibr" rid="article-26948.r16">[16]</xref><xref ref-type="bibr" rid="article-26948.r17">[17]</xref><xref ref-type="bibr" rid="article-26948.r11">[11]</xref>&#x000a0;Mediation of the vlPAG-RVLM system occurs with 5-HT, as demonstrated by inhibition of defense responses with microinjections of 5-HT. Further, the stimulation of 5-HT&#x000a0;on GABAergic neurons in the vPAG demonstrates anxiolysis.<xref ref-type="bibr" rid="article-26948.r15">[15]</xref></p>
        <p>Overall, defensive behavior can subdivide into immediate and long-term responses. Stimulation of the dorsolateral and lateral PAG demonstrates short-term fight or flight with increases in heart rate and blood pressure, increased alertness, and transmission of non-opioid antinociceptive signals.<xref ref-type="bibr" rid="article-26948.r11">[11]</xref>&#x000a0;Stimulation of the vlPAG demonstrated more long term learned behaviors, including freezing and opioid-mediated antinociceptive signals.<xref ref-type="bibr" rid="article-26948.r11">[11]</xref>&#x000a0;The co-occurrence of fear and anti-nociceptive signals underlies future avoidance and learning.<xref ref-type="bibr" rid="article-26948.r18">[18]</xref>&#x000a0;Fear induced antinociception is evoked with stimulation of the dlPAG and superior colliculus.<xref ref-type="bibr" rid="article-26948.r15">[15]</xref></p>
        <p>
<italic toggle="yes">MIGRAINES</italic>
</p>
        <p>The PAG has been studied for even more specific functions, such as its role in migraines. Interestingly, the PAG has been implicated in the pathophysiology of migraines, possibly being the &#x0201c;generator&#x0201d; sites for migraine attacks. Increased non-heme iron deposition in the PAG for those with current migraines compared to those without a migraine relate to this evidence, although it is not clear if this is cause or consequence of the attacks.<xref ref-type="bibr" rid="article-26948.r6">[6]</xref></p>
      </sec>
      <sec id="article-26948.s3" sec-type="Embryology">
        <title>Embryology</title>
        <p>The development of the PAG and the midbrain happens quite early in gestation, beginning with the ectoderm, one of the three main germinal layers. The neural ectoderm begins to develop by the third week, giving rise to the neural ectoderm and notochord by the mid-fourth week of development. The notochord, responsible for the longitudinal axis of the brain, gives rise to the three main layers of the primitive brain, including the mesencephalon, which is the embryologic source of the midbrain.</p>
      </sec>
      <sec id="article-26948.s4" sec-type="Blood Supply and Lymphatics">
        <title>Blood Supply and Lymphatics</title>
        <p>The development of the PAG and the midbrain happens quite early in gestation, beginning with the ectoderm, one of the three main germinal layers. The neural ectoderm begins to develop by the 3rd week, giving rise to the neural ectoderm and notochord by the mid-fourth week of development. The notochord, responsible for the longitudinal axis of the brain, gives rise to the three main layers of the primitive brain, including the mesencephalon, which is the embryologic source of the midbrain.</p>
      </sec>
      <sec id="article-26948.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The primary clinical focus concerning the PAG involves its antinociceptive endogenous opioid and non-opioid mediated pain control.&#x000a0;&#x000a0;This concept has support from studies demonstrating both lower activation of the PAG in chronic pain states, such as lower back pain and complex regional pain syndrome, as well as distractions from pain with upregulation of the PAG.<xref ref-type="bibr" rid="article-26948.r13">[13]</xref>&#x000a0;As such, receptors within the PAG are a specific focus for pain research. For example, the observation that pre-synaptic GABA receptors are more sensitive highlights baclofen and other alpha-2 receptor agents in pain control.<xref ref-type="bibr" rid="article-26948.r9">[9]</xref>&#x000a0;Beyond pharmacology, other modalities, such as deep brain stimulation (DBS), have targeted the PAG for intractable pain.<xref ref-type="bibr" rid="article-26948.r12">[12]</xref></p>
        <p>Through its role in arousal and pain, the PAG has a major involvement in disease states, including anxiety, panic disorders, and depression. Chronic stress states have shown links to despair and depression-like behaviors in mice, for example. Tail suspension tests or forced swim tests in mice led to suppressed glutamate in vlPAG leading to maladaptive and depression-like behaviors.<xref ref-type="bibr" rid="article-26948.r4">[4]</xref>&#x000a0;Panic attacks have also shown links to projections from the ventromedial hypothalamus (VMH) and the dPAG as a chemical blockade of this pathway in rats terminated escape, freezing, and aversive behaviors.<xref ref-type="bibr" rid="article-26948.r5">[5]</xref></p>
      </sec>
      <sec id="article-26948.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26948&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26948">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26948/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26948">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26948.s7">
        <fig id="article-26948.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Periaqueductal pain pathways, sketched Sketched by Miriam Mokhtar MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PAG__Pain__Pathways" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26948.s8">
        <title>References</title>
        <ref id="article-26948.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baptista-de-Souza</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pelarin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Canto-de-Souza</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nunes-de-Souza</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Canto-de-Souza</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Interplay between 5-HT<sub>2C</sub> and 5-HT<sub>1A</sub> receptors in the dorsal periaqueductal gray in the modulation of fear-induced antinociception in mice.</article-title>
            <source>Neuropharmacology</source>
            <year>2018</year>
            <month>Sep</month>
            <day>15</day>
            <volume>140</volume>
            <fpage>100</fpage>
            <page-range>100-106</page-range>
            <pub-id pub-id-type="pmid">30056125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benarroch</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Descending monoaminergic pain modulation: bidirectional control and clinical relevance.</article-title>
            <source>Neurology</source>
            <year>2008</year>
            <month>Jul</month>
            <day>15</day>
            <volume>71</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-21</page-range>
            <pub-id pub-id-type="pmid">18625968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calvino</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Grilo</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Central pain control.</article-title>
            <source>Joint Bone Spine</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-6</page-range>
            <pub-id pub-id-type="pmid">15922645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression.</article-title>
            <source>Neuropsychopharmacology</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>302</fpage>
            <page-range>302-312</page-range>
            <pub-id pub-id-type="pmid">28853438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ullah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dos Anjos-Garcia</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mendes-Gomes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elias-Filho</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Falconi-Sobrinho</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Freitas</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AU</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coimbra</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Connexions between the dorsomedial division of the ventromedial hypothalamus and the dorsal periaqueductal grey matter are critical in the elaboration of hypothalamically mediated panic-like behaviour.</article-title>
            <source>Behav Brain Res</source>
            <year>2017</year>
            <month>Feb</month>
            <day>15</day>
            <volume>319</volume>
            <fpage>135</fpage>
            <page-range>135-147</page-range>
            <pub-id pub-id-type="pmid">27856260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welch</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Nagesh</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aurora</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Gelman</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?</article-title>
            <source>Headache</source>
            <year>2001</year>
            <season>Jul-Aug</season>
            <volume>41</volume>
            <issue>7</issue>
            <fpage>629</fpage>
            <page-range>629-37</page-range>
            <pub-id pub-id-type="pmid">11554950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carrive</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The periaqueductal gray and defensive behavior: functional representation and neuronal organization.</article-title>
            <source>Behav Brain Res</source>
            <year>1993</year>
            <month>Dec</month>
            <day>20</day>
            <volume>58</volume>
            <issue>1-2</issue>
            <fpage>27</fpage>
            <page-range>27-47</page-range>
            <pub-id pub-id-type="pmid">8136048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Menant</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zelena</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chaillou</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The benefits of magnetic resonance imaging methods to extend the knowledge of the anatomical organisation of the periaqueductal gray in mammals.</article-title>
            <source>J Chem Neuroanat</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>77</volume>
            <fpage>110</fpage>
            <page-range>110-120</page-range>
            <pub-id pub-id-type="pmid">27344962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Differential sensitivity of presynaptic and postsynaptic GABAB receptors in rat ventrolateral periaqueductal gray.</article-title>
            <source>Neuroreport</source>
            <year>2017</year>
            <month>Dec</month>
            <day>13</day>
            <volume>28</volume>
            <issue>18</issue>
            <fpage>1221</fpage>
            <page-range>1221-1224</page-range>
            <pub-id pub-id-type="pmid">28926472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourbia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pertovaara</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Involvement of the periaqueductal gray in the descending antinociceptive effect induced by the central nucleus of amygdala.</article-title>
            <source>Physiol Res</source>
            <year>2018</year>
            <month>Aug</month>
            <day>16</day>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>647</fpage>
            <page-range>647-655</page-range>
            <pub-id pub-id-type="pmid">29750883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lovick</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>The periaqueductal gray-rostral medulla connection in the defence reaction: efferent pathways and descending control mechanisms.</article-title>
            <source>Behav Brain Res</source>
            <year>1993</year>
            <month>Dec</month>
            <day>20</day>
            <volume>58</volume>
            <issue>1-2</issue>
            <fpage>19</fpage>
            <page-range>19-25</page-range>
            <pub-id pub-id-type="pmid">8136045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roizen</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Newfield</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Eger</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Hosobuchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lamb</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Reduced anesthetic requirement after electrical stimulation of periaqueductal gray matter.</article-title>
            <source>Anesthesiology</source>
            <year>1985</year>
            <month>Feb</month>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>120</fpage>
            <page-range>120-3</page-range>
            <pub-id pub-id-type="pmid">3970361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freund</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wunderlich</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Stuber</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Steffen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mentzel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The role of periaqueductal gray and cingulate cortex during suppression of pain in complex regional pain syndrome.</article-title>
            <source>Clin J Pain</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>796</fpage>
            <page-range>796-804</page-range>
            <pub-id pub-id-type="pmid">21593662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGaraughty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farr</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Heinricher</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Lesions of the periaqueductal gray disrupt input to the rostral ventromedial medulla following microinjections of morphine into the medial or basolateral nuclei of the amygdala.</article-title>
            <source>Brain Res</source>
            <year>2004</year>
            <month>May</month>
            <day>29</day>
            <volume>1009</volume>
            <issue>1-2</issue>
            <fpage>223</fpage>
            <page-range>223-7</page-range>
            <pub-id pub-id-type="pmid">15120601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Oliveira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Oliveira</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Falconi-Sobrinho</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>da Silva Soares</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coimbra</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>5-Hydroxytryptamine<sub>2A/2C</sub> receptors of nucleus raphe magnus and gigantocellularis/paragigantocellularis pars &#x003b1; reticular nuclei modulate the unconditioned fear-induced antinociception evoked by electrical stimulation of deep layers of the superior colliculus and dorsal periaqueductal grey matter.</article-title>
            <source>Behav Brain Res</source>
            <year>2017</year>
            <month>Jan</month>
            <day>01</day>
            <volume>316</volume>
            <fpage>294</fpage>
            <page-range>294-304</page-range>
            <pub-id pub-id-type="pmid">27616344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Back</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Carobrez</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation.</article-title>
            <source>Neuropharmacology</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>135</volume>
            <fpage>399</fpage>
            <page-range>399-411</page-range>
            <pub-id pub-id-type="pmid">29596901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Periaqueductal Gray Neuronal Activities Underlie Different Aspects of Defensive Behaviors.</article-title>
            <source>J Neurosci</source>
            <year>2016</year>
            <month>Jul</month>
            <day>20</day>
            <volume>36</volume>
            <issue>29</issue>
            <fpage>7580</fpage>
            <page-range>7580-8</page-range>
            <pub-id pub-id-type="pmid">27445137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26948.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway.</article-title>
            <source>Mol Pain</source>
            <year>2018</year>
            <season>Jan-Dec</season>
            <volume>14</volume>
            <fpage>1744806918783535</fpage>
            <pub-id pub-id-type="pmid">29900804</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
